Krsnaa Diagnostics Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 4,628 shares,. Its Average Traded Price (ATP) is ₹514.56, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3 @ ₹514.90.
Krsnaa Diagnostics has an upper circuit limit of ₹621.65 and a lower circuit limit of ₹414.45. The total value traded stands at ₹23.81 L, and the delivery percentage for the day is 45.28%.
The stock is currently traded with a market lot size of 1. Krsnaa Diagnostics also offers a dividend yield of 0.39%.
Krsnaa Diagnostics Share Price Chart
Krsnaa Diagnostics Share Key Metrics
Volume
4628.00
Market Cap
1715.19 CR
LTQ@LTP
3@514.90
ATP
514.56
Var Margin
15.91 %
Circuit Range
414.45-621.65
Delivery %
45.28 %
Value
23.81 L
ASM/GSM
No
Market Lot
1
Krsnaa Diagnostics Resistance and Support
Pivot 512.02
Resistance
First Resistance
528.94
Second Resistance
539.82
Third Resistance
556.74
Support
First Support
501.14
Second Support
484.22
Third Support
473.34
Krsnaa Diagnostics Shareholding Pattern
View More- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Krsnaa Diagnostics Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-02 | Quarterly Results |
| 2026-08-13 | Quarterly Results & A.G.M. |
| 2026-05-25 | Audited Results & Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-11 | Quarterly Results |
| 2025-05-12 | Audited Results & Final Dividend |
| 2025-02-12 | Quarterly Results |
| 2024-10-25 | Quarterly Results |
| 2024-08-06 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2025-09-12 | 2025-09-12 | View More |
Krsnaa Diagnostics News
Krsnaa Diagnostics Ltd - 543328 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Krsnaa Diagnostics secured a PPP project from the Municipal Corporation of Delhi to finance, establish, and operate CT Scan and MRI facilities at three public hospitals. The concession period is 10 years, extendable by 5 years, with commercial operations expected within 180 days of site handover.
Nov 03 2026 14:33:59
Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Krsnaa Diagnostics reported its highest-ever quarterly revenue of Rs.271 crores in Q2 FY27, up 32% YoY. Net profit stood at Rs.24.6 crores, with margin moderation attributed to upfront expenditure. Strong retail momentum drove a 35% YoY retail revenue growth.
Nov 02 2026 18:38:24
Krsnaa Diagnostics Ltd - 543328 - Board Meeting Outcome for Outcome Of Board Meeting For Q2 FY 2026-27
Krsnaa Diagnostics reported Q2 cons. revenue of ₹270.97 cr (up 31.5% YoY) and net profit of ₹24.59 cr (up 2.7% YoY). The company has deposited ₹10.27 cr under protest related to an ongoing income tax appeal.
Nov 02 2026 15:06:48
Krsnaa Diagnostics Ltd - 543328 - Board Meeting Outcome for Outcome Of Board Meeting For Q2 FY 2026-27
Krsnaa Diagnostics reported Q2 FY27 cons. revenue of ₹270.97 crores (up 31.5% YoY) and net profit of ₹24.59 crores (up 2.7% YoY). The company has also deposited ₹10.28 crores under protest against an ongoing income tax demand appeal.
Nov 02 2026 15:06:04
Krsnaa Diagnostics Ltd - 543328 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter And Half Year Ended September 30Th, 2026.
Krsnaa Diagnostics board will meet on 02 Nov 2026 for financial results.
Oct 26 2026 22:10:03
Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Krsnaa Diagnostics announced a strategic AI collaboration with AZmed to evaluate its AZtrauma solution for X-ray reporting. The integration aims to enhance operational productivity and scalability across its 5 million annual X-ray operations.
Oct 22 2026 07:34:18
Krsnaa Diagnostics Ltd - 543328 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Krsnaa Diagnostics' promoter group, including Krsnaa Diagnostics (Mumbai) Pvt Ltd and PAC, acquired 16.21 lakh fully convertible warrants on a preferential basis at Rs.566 each. This allotment increases their diluted shareholding from 26.30% to 29.70%.
Oct 16 2026 10:25:35
Krsnaa Diagnostics Management
| Name | Position |
|---|---|
| Sujoy Sudipta Bose | Company Secretary & Compliance Officer |
| Rajendra Mutha | Chairman |
Krsnaa Diagnostics Similar Stocks
Venus Remedies Ltd.
1700.50
255.90 (17.71%)
Syncom Formulations (India) Ltd.
20.33
0.09 (0.44%)
Suraksha Diagnostic Ltd.
349.05
8.05 (2.36%)
NGL Fine-Chem Ltd.
3079.60
-38.50 (1.23%)
Amrutanjan Health Care Ltd.
509.00
0.20 (0.04%)
Anlon Healthcare Ltd.
26.59
-0.14 (0.52%)
Jagsonpal Pharmaceuticals Ltd.
216.00
-0.73 (0.34%)
Shalby Ltd.
127.99
0.63 (0.49%)
KMC Speciality Hospitals (India) Ltd.
181.58
5.15 (2.92%)
Krsnaa Diagnostics FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in KRSNAA
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC